CG - Cell Generation

Cell Generation is a leading pharmaceutical manufacturing company dedicated to providing high-quality human blood-derived cells for research and clinical applications. Located in Jerusalem BioPark, Hadassah Ein Kerem, Jerusalem, IL, Cell Generation supports advancements in cell and gene therapies, immuno-oncology, and translational research. The company's ethically sourced, IRB-approved materials from healthy and patient donors ensure reliability and scientific integrity.

Cell Generation offers a comprehensive range of products and services, including fresh and cryopreserved PBMCs, mobilized PBMCs and leukopaks, and enriched subpopulations such as CD3, CD4, CD8, CD14, CD19, CD34, and CD56. With robust QC, documentation, and regulatory support, Cell Generation provides clinical-use materials and custom collections tailored to specific protocols and timelines. The company's expertise extends to disease-specific material, including oncology, autoimmune, and infectious diseases.

Committed to powering progress from research to therapy, Cell Generation combines deep experience in applied and translational research with a focus on clinical trials. The company's flexibility, reliability, and dedication to scientific partnership make it an ideal collaborator for optimizing manufacturing workflows and sourcing cells for IND-enabling studies. Cell Generation looks forward to contributing to the next breakthrough. We invite the manager of Cell Generation to create a customized and exclusive company showcase and product listing on our platform.